November Editors’ Picks from AACR Journals
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
September is Childhood Cancer Awareness Month. Childhood cancer is relatively rare, but it is a devastating diagnosis that can...
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
This month, the editors of the AACR’s journals have chosen to highlight an analysis of birth characteristics and risk...
Every month, the editors from the portfolio of scientific journals published by the AACR select one “must read” article...